Correlation Between Dynavax Technologies and DarioHealth Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and DarioHealth Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and DarioHealth Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and DarioHealth Corp, you can compare the effects of market volatilities on Dynavax Technologies and DarioHealth Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of DarioHealth Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and DarioHealth Corp.

Diversification Opportunities for Dynavax Technologies and DarioHealth Corp

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dynavax and DarioHealth is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and DarioHealth Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DarioHealth Corp and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with DarioHealth Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DarioHealth Corp has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and DarioHealth Corp go up and down completely randomly.

Pair Corralation between Dynavax Technologies and DarioHealth Corp

Given the investment horizon of 90 days Dynavax Technologies is expected to under-perform the DarioHealth Corp. But the stock apears to be less risky and, when comparing its historical volatility, Dynavax Technologies is 11.02 times less risky than DarioHealth Corp. The stock trades about -0.07 of its potential returns per unit of risk. The DarioHealth Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  77.00  in DarioHealth Corp on October 5, 2024 and sell it today you would earn a total of  2.00  from holding DarioHealth Corp or generate 2.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dynavax Technologies  vs.  DarioHealth Corp

 Performance 
       Timeline  
Dynavax Technologies 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
DarioHealth Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DarioHealth Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Dynavax Technologies and DarioHealth Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dynavax Technologies and DarioHealth Corp

The main advantage of trading using opposite Dynavax Technologies and DarioHealth Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, DarioHealth Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will offset losses from the drop in DarioHealth Corp's long position.
The idea behind Dynavax Technologies and DarioHealth Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance